Shots: BlueRock to get $240M in cash as upfront and $360M as development milestones. In 2016, Bayer and Versant Ventures formed a joint venture establishing BlueRock Therapeutics, Bayer currently holds […]readmore
Tags : BlueRock Therapeutics
Shots: Editas & BlueRock enter in to research collaboration to develop engineered cell therapies/ allogeneic pluripotent stem cell (PSC) lines by the combination of Editas’ CRISPR & BlueRock’s iPSC in […]readmore